TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    Why Aphria Inc. Ought to Ditch TSX

    Aphria Inc. (TSX:APH), one of the best run Canadian cannabis companies, ought to call the TSX’s bluff and move to…

    Read more »

    Investing

    Why Aphria Inc. Is My Least Favourite TSX-Traded Marijuana Stock

    Why Aphria Inc. (TSX:APH) may be the riskiest of the risky Canadian marijuana stocks. Here's what you need to know…

    Read more »

    The Motley Fool
    Tech Stocks

    Looking for Growth? Forget Cannabis. Go Retro With These 2 Previous Growth Kings

    Do Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and BlackBerry Ltd. (TSX:BB)(NYSE:BB) really have more upside than cannabis firms or companies such as Shopify…

    Read more »

    Investing

    Is Canopy Growth Corp. a $10 Billion Company?

    Canopy Growth Corp (TSX:WEED) is already up more than 40% in 2018. How much higher can the share price go?

    Read more »

    The Motley Fool
    Investing

    Could Valeant Pharmaceuticals Intl Inc. Be the Rebound Stock of the Year?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a hot business with promising revenue drivers in the new year. With the tailwinds…

    Read more »

    Investing

    Is Buying Oversold Stocks an Effective Strategy?

    If you had bought Canadian National Railway Company (TSX:CNR)(NYSE:CNI) back when it was oversold in August, you would have earned a…

    Read more »

    Investing

    Will Investors Finally See the Demise of This Company in 2018?

    With an increasing interest expense, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be ready for bankruptcy in 2018.

    Read more »

    Investing

    3 Reasons the Canadian Economy Could Decline in 2018

    Dollarama Inc. (TSX:DOL) and other retailers are going to be severely impacted by rising minimum wages in 2018.

    Read more »

    Tech Stocks

    3 Turnaround Candidates for 2018 You Should Consider Now

    Beleaguered companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and others could stand to finally see a turnaround in 2018.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc Jumped 35% Last Month: Is the Stock Taking off?

    Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) has seen its stock soar recently and investors may want to take a second look…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Surged Almost 10% Today

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is clearly making progress under its new CEO, but there are still many hurdles to…

    Read more »

    time is money compounding
    Investing

    Valeant Pharmaceuticals Intl Inc. Is up! Time to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to pay down and refinance its debt to more favourable terms. As the business…

    Read more »